Monday, July 23, 2012

Biotech Day: Monday's national biotech news

From the 40 business journals of American City Business Journals …

Covance animal testing lab for sale in Vienna (Washington Business Journal)
Princeton, N.J.-based Covance, one of the nation's largest drug development companies, is beginning to market its 113,000-square-foot animal testing lab in Vienna for sale, The Washington Post reported.

Discovery leads to launch of biotech company Exscien (Birmingham Business Journal)
A scientific discovery made at the University of South Alabama College of Medicine has helped launch biotech company Exscien in Mobile. According to the Press-Register, Exscien was recently awarded a grant by the National Institutes of Health to support the development of a new drug aimed at preventing and reversing acute lung injury.

Astex leukemia drug nets European recommendation (San Francisco Business Times)
An advisory committee to Europe’s drug regulator recommended Friday that the agency approve a drug licensed out of Dublin-based Astex Pharmaceuticals Inc. for patients with acute myeloid leukemia. The European Medicines Agency’s Committee for Medical Products for Human Use recommended that Dacogen injections be approved for people 65 or older with newly diagnosed or secondary AML who are not eligible for standard chemotherapy.

No comments:

Post a Comment